Indero Celebrates Significant Milestone in Clinical Trials
Specialized contract research organization (CRO) Indero proudly marks the launch of its 40th RTSM study, reinforcing its commitment to advancing clinical trial efficiency. This achievement is made possible by their collaboration with Veeva Systems, a leader in cloud software for the life sciences sector.
Enhancing Operational Efficiency with Veeva RTSM
By standardizing operations through Veeva RTSM, Indero is driving enhanced operational efficiency and quicker study timelines. The partnership allows Indero to leverage advanced Randomization and Trial Supply Management (RTSM) capabilities. This integration is smooth and effective, resulting in significant benefits for sponsors, sites, and patients alike, enabling faster delivery of therapies to the market.
Streamlined Processes Lead to Better Collaboration
According to Eric Hardy, Senior Director of Biometrics at Indero, the Veeva RTSM platform has been a game-changer in optimizing their clinical trial operations. Hardy emphasizes that their processes have become more efficient, promoting closer collaboration in executing studies flawlessly. The ability to expedite processes directly influences the time it takes to bring new therapies to market, which has a positive impact on improving patient access to innovative treatment options.
Long-Term Success Through Continuous Improvement
The achievement of launching the 40th RTSM study reflects the ongoing partnership between Indero and Veeva. Since initiating the use of Veeva RTSM, Indero has been dedicated to refining and enhancing its processes. This long-term relationship aims for enduring success in clinical trials, focusing on a standardized approach that offers reliability and efficiency.
Dedicated to Excellence in Clinical Research
Steve Simmerman, General Manager of Veeva RTSM, commends Indero’s commitment to maximizing the efficiency of their studies through an enterprise-wide standard approach. This shared vision not only accelerates study timelines but also exemplifies a modern, streamlined strategy that has the potential to transform industry practices. Indero's strategic move to embrace advanced technology showcases their focus on excellence and adaptability in clinical research.
About Indero and Their Commitment to Patients
Indero is dedicated to supporting the life sciences by ensuring that clinical trials are executed with precision and expertise. Their mission focuses on empowering clinical development with an emphasis on operational excellence and patient-centric approaches. Through continuous learning and adaptation, Indero aims to overcome challenges in clinical research and deliver timely and effective therapies.
Contact Information
For further inquiries about Indero's clinical research initiatives or collaborations, please reach out to their team. They are excited to share how their innovative approaches can make a difference in the life sciences.
Frequently Asked Questions
What is Indero's 40th RTSM study about?
Indero's 40th RTSM study marks a significant milestone in their commitment to enhancing clinical trial operations and improving efficiencies in bringing therapies to market.
How does Veeva RTSM improve clinical trial processes?
Veeva RTSM standardizes operations, enabling Indero to achieve quicker study timelines and increased collaboration, leading to more effective execution of clinical trials.
Who is involved in the partnership between Indero and Veeva?
The partnership involves Indero, a specialized CRO, and Veeva Systems, a leader in cloud software tailored for the life sciences industry.
What benefits do sponsors, sites, and patients gain from this collaboration?
Thanks to enhanced operational efficiency and streamlined processes, sponsors, sites, and patients benefit from faster access to new therapies and improved trial execution.
How does Indero maintain long-term success in its studies?
Indero focuses on continuous improvement by refining its processes and maintaining a strong partnership with Veeva to ensure ongoing success in clinical development efforts.
